News

BioTime Co-CEO Dr. Michael West to Deliver Presentation as Part of Biotech Panel at Mauldin Economics’ Strategic Investment Conference on May 24

BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that Co-Chief Executive Officer Michael D. West, Ph.D., is delivering a presentation as part of a panel on biotechnology at the Mauldin Economics’ Strategic Investment Conference on Wednesday, May 24 at 3:20pm EDT at the Omni Orlando Resort in Florida.

2017-06-27T12:12:33+00:00